ProQR Therapeutics N.V. Cash Flows From Used In Operations
ProQR Therapeutics N.V. (PRQR) reported Cash Flows From Used In Operations of -EUR 54.59 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperations · last filed 2026-03-12
- ProQR Therapeutics N.V. cash flows from used in operations for the quarter ending 2025-12-31 was -13.66M EUR.
- ProQR Therapeutics N.V. cash flows from used in operations for the quarter ending 2025-09-30 was -12.60M EUR.
- ProQR Therapeutics N.V. cash flows from used in operations for the quarter ending 2025-06-30 was -11.95M EUR.
- ProQR Therapeutics N.V. cash flows from used in operations for the quarter ending 2025-03-31 was -16.38M EUR.
| Period end | Cash Flows From Used In Operations 3 month | Cash Flows From Used In Operations 3 month as first filed | Cash Flows From Used In Operations 6 month | Cash Flows From Used In Operations 9 month | Cash Flows From Used In Operations 12 month | Cash Flows From Used In Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -13.66M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -26.26M EUR derived: sum of 2 quarters · filed 2026-03-12 | -38.21M EUR derived: sum of 3 quarters · filed 2026-03-12 | -54.59M EUR 20-F · filed 2026-03-12 | ||
| 2025-09-30 | -12.60M EUR 6-K · filed 2025-11-06 | -24.55M EUR derived: sum of 2 quarters · filed 2025-11-06 | -40.93M EUR 6-K · filed 2025-11-06 | -50.95M EUR derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-06-30 | -11.95M EUR 6-K · filed 2025-08-07 | -28.32M EUR 6-K · filed 2025-08-07 | -38.35M EUR derived: sum of 3 quarters · filed 2026-03-12 | -44.65M EUR derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-03-31 | -16.38M EUR 6-K · filed 2025-05-08 | -26.40M EUR derived: sum of 2 quarters · filed 2026-03-12 | -32.70M EUR derived: sum of 3 quarters · filed 2026-03-12 | -39.58M EUR derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-12-31 | -10.03M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -16.32M EUR derived: sum of 2 quarters · filed 2026-03-12 | -23.20M EUR derived: sum of 3 quarters · filed 2026-03-12 | -39.07M EUR 20-F · filed 2026-03-12 | ||
| 2024-09-30 | -6.30M EUR 6-K · filed 2025-11-06 | -13.17M EUR derived: sum of 2 quarters · filed 2025-11-06 | -29.05M EUR 6-K · filed 2025-11-06 | -34.50M EUR derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-06-30 | -6.88M EUR 6-K · filed 2025-08-07 | -22.75M EUR 6-K · filed 2025-08-07 | -28.20M EUR derived: sum of 3 quarters · filed 2026-03-12 | -36.59M EUR derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-03-31 | -15.87M EUR 6-K · filed 2025-05-08 | -21.33M EUR derived: sum of 2 quarters · filed 2026-03-12 | -29.72M EUR derived: sum of 3 quarters · filed 2026-03-12 | -40.75M EUR derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2023-12-31 | -5.45M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -13.85M EUR derived: sum of 2 quarters · filed 2026-03-12 | -24.88M EUR derived: sum of 3 quarters · filed 2026-03-12 | 19.67M EUR 20-F · filed 2026-03-12 | ||
| 2023-09-30 | -8.39M EUR 6-K · filed 2024-11-07 | -19.43M EUR derived: sum of 2 quarters · filed 2024-11-07 | 25.12M EUR 6-K · filed 2024-11-07 | 7.46M EUR derived: sum of 4 quarters · filed 2025-03-13 | ||
| 2023-06-30 | -11.03M EUR 6-K · filed 2024-08-08 | 33.51M EUR 6-K · filed 2024-08-08 | 15.85M EUR derived: sum of 3 quarters · filed 2025-03-13 | 1.58M EUR derived: sum of 4 quarters · filed 2025-03-13 | ||
| 2023-03-31 | 44.55M EUR 6-K · filed 2024-05-09 | 26.88M EUR derived: sum of 2 quarters · filed 2025-03-13 | 12.61M EUR derived: sum of 3 quarters · filed 2025-03-13 | -973.00K EUR derived: sum of 4 quarters · filed 2025-03-13 | ||
| 2022-12-31 | -17.66M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | -31.93M EUR derived: sum of 2 quarters · filed 2025-03-13 | -45.52M EUR derived: sum of 3 quarters · filed 2025-03-13 | -64.76M EUR 20-F · filed 2025-03-13 | ||
| 2022-09-30 | -14.27M EUR 6-K · filed 2023-11-07 | -27.86M EUR derived: sum of 2 quarters · filed 2023-11-07 | -47.10M EUR 6-K · filed 2023-11-07 | -42.76M EUR derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | -13.59M EUR 6-K · filed 2023-08-03 | -32.83M EUR 6-K · filed 2023-08-03 | -28.49M EUR derived: sum of 3 quarters · filed 2023-08-03 | -35.95M EUR derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | -19.24M EUR 6-K · filed 2023-05-16 | -14.90M EUR derived: sum of 2 quarters · filed 2023-05-16 | -22.36M EUR derived: sum of 3 quarters · filed 2023-05-16 | -31.72M EUR derived: sum of 4 quarters · filed 2023-05-16 | ||
| 2021-12-31 | 4.34M EUR 6-K · filed 2022-02-24 | -3.12M EUR derived: sum of 2 quarters · filed 2022-11-09 | -12.47M EUR derived: sum of 3 quarters · filed 2022-11-09 | -23.65M EUR 20-F · filed 2024-03-13 | ||
| 2021-09-30 | -7.46M EUR 6-K · filed 2022-11-09 | -16.82M EUR derived: sum of 2 quarters · filed 2022-11-09 | -27.99M EUR 6-K · filed 2022-11-09 | -39.42M EUR derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -9.36M EUR 6-K · filed 2022-08-04 | -20.53M EUR 6-K · filed 2022-08-04 | -31.96M EUR derived: sum of 3 quarters · filed 2022-08-04 | -41.07M EUR derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | -11.18M EUR 6-K · filed 2022-05-05 | -22.60M EUR derived: sum of 2 quarters · filed 2022-05-05 | -31.71M EUR derived: sum of 3 quarters · filed 2022-05-05 | -42.22M EUR derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | -11.43M EUR 6-K · filed 2022-02-24 | -11.43M EUR 6-K · filed 2021-02-25 | -20.54M EUR derived: sum of 2 quarters · filed 2022-02-24 | -31.04M EUR derived: sum of 3 quarters · filed 2022-02-24 | -46.07M EUR 20-F · filed 2023-03-29 | -46.07M EUR 6-K · filed 2021-02-25 |
| 2020-09-30 | -9.11M EUR 6-K · filed 2021-11-04 | -19.61M EUR derived: sum of 2 quarters · filed 2021-11-04 | -34.65M EUR 6-K · filed 2021-11-04 | |||
| 2020-06-30 | -10.50M EUR 6-K · filed 2021-08-05 | -25.54M EUR 6-K · filed 2021-08-05 | ||||
| 2019-12-31 | -12.53M EUR 6-K · filed 2021-02-25 | -21.38M EUR derived: sum of 2 quarters · filed 2021-02-25 | -32.20M EUR derived: sum of 3 quarters · filed 2021-02-25 | -44.59M EUR 6-K · filed 2021-02-25 | ||
| 2019-09-30 | -8.85M EUR 6-K · filed 2020-11-16 | -19.67M EUR derived: sum of 2 quarters · filed 2020-11-16 | -32.06M EUR 6-K · filed 2020-11-16 | |||
| 2019-06-30 | -10.82M EUR 6-K · filed 2020-08-06 | -23.21M EUR 6-K · filed 2020-08-06 |